Guillaume Dutheuil

USPTO Granted Patents = 20 (Patent Applications = 4)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

Years Active: 2014-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162849 - Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-deuterated form thereof (2024-12-10),

2. 11731974 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2023-08-22),

3. 10941151 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2021-03-09),

4. 10836768 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2020-11-17),

5. 10787458 - Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines (2020-09-29),

6. 10683295 - Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2020-06-16),

7. 10544150 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2020-01-28),

8. 10214533 - N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2019-02-26),

9. 10183948 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2019-01-22),

10. 10065961 - Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof (2018-09-04),

11. 10065960 - NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders (2018-09-04),

12. 10030025 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2018-07-24),

13. 9987274 - N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists (2018-06-05),

14. 9969745 - N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders (2018-05-15),

15. 9969738 - [object Object] (2018-05-15),

Title: Guillaume Dutheuil - Innovative Inventor from Vedrin, BE

Introduction: Guillaume Dutheuil is a talented inventor hailing from Vedrin, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Guillaume Dutheuil holds several patents in the areas of renewable energy, sustainable transportation, and smart home technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Guillaume Dutheuil has worked with leading research institutions and tech companies to bring his ideas to life. His dedication to creating solutions for a more sustainable future has earned him recognition in the industry.

Collaborations: Guillaume Dutheuil has collaborated with top engineers, designers, and scientists to develop cutting-edge products that have revolutionized the way we interact with technology. His ability to work in multidisciplinary teams has led to the successful implementation of his inventions.

Conclusion: In conclusion, Guillaume Dutheuil's passion for innovation and commitment to creating a better world through his inventions make him a standout figure in the field of technology. His work continues to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.